BridgeMD
New treatment option for Pilonidal Disease
Official title Topical Anti-Androgens in Pilonidal Sinus Disease
ClinicalTrials.gov ID: NCT06286397
What this study is testing
What is 1% Clascoterone?
1% Clascoterone is an investigational medicine, given as an once-weekly treatment applied to the skin, being studied as a potential treatment for pilonidal disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this randomized clinical trial is to test the topical drug clascoterone in patients with pilonidal disease, which is a common, benign skin condition of the gluteal cleft. The main questions it aims to answer are: Does clascoterone improve the severity of pilonidal disease as scored by a physician?
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 and above
- Diagnosis of Pilonidal Disease
- Willingness to comply with study procedures and availability for duration of study
- Ability to apply topical medications and willing to adhere to regimen
You likely can't join if
- Current use of any topical medication to natal cleft
- Presence of pilonidal-associated abscess
- Pregnancy or lactation
- Allergic reaction to components of 1% clascoterone cream
- Febrile illness within 7 days
- Treatment with another investigational drug within three months
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.